Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma

Jennifer L. Clarke, Fabio M. Iwamoto, Joohee Sul, Katherine Panageas, Andrew B. Lassman, Lisa M. DeAngelis, Adília Hormigo, Craig P. Nolan, Igor Gavrilovic, Sasan Karimi, Lauren E. Abrey

Research output: Contribution to journal › Article › peer-review

161 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences